Saturday, 29 November 2025

Week 538 Review - Not a bad week for the SIPP but a drop for the ISA.

A positive week despite a drop in OPTI:Optibiotix and PBX:Probiotix Health. The ISA is more exposed to those than the SIPP so had a negative week, whereas the SIPP finished up despite banking some profits. The deficit between cost and value narrowed by £456 to £146,603 and the deficit between injection and value narrowed to £65,110. Total portfolio value increased to £114,458.

Worst performer was PBX:Probiotix Health which dropped 8% just a week after falling 7%. I fear these are set to languish for some time. OPTI:Optibiotix dropped 4% and between them they caused most of the damage to the ISA.

BEZ:Beazley had a dreadful week, dropping 7% after a trading statement that lowered outlook for the following year. I had suspended buying these in my monthly savings as they had been creeping up, but I may look to add some more as I think the drop is over-done.

They were the only big losers this week.

FXPO:Ferrexpo climbed a massive 29% on renewed hopes for a Ukrainian peace deal, but they are still 85% down so I'm not allowing them anywhere near Share of the Week despite having to report on them again now.

ASHM:Ashmore GroupKNOS:Kainos Group, POLR:Polar Capital and PRU:Prudential all went up 5% in what seemed like a reversal of last week's drop.

PSN:Persimmon and RAT:Rathbones went up 6% for the same reason, as did TLOU:Tlou Energy, but that's more the usual yo-yo of this share.

AFC:AFC Energy went up a healthy 8% given there was no news.

IHP:Integrafin recovered from last week's big drop with a 10% increase which put my holding back into profit.

Share of the Week is PAF:Pan African Resources which also rose 10% despite going ex-dividend and is now 227% up, so I sold a small amount to bank some profit after qualifying for the dividend. I probably shouldn't sell any more.

Here's the ISA and shares portfolio after week 18 of year 11.

Weekly Change
Cash£90.86    +£0
Portfolio cost£116,758.09+£0
Portfolio sell value
(bid price-commission)
£35,710.93(-69.4%)-£335.99
Potential profits£198.89+£58.65
Yr 11 Dividends£25.32
+£0
Yr 11 Interest£0.75            +£0
Yr 11 Profit from sales£487.56+£0
Yr 11 proj avg monthly profit£116.00(1.6%)-£6.82
Total Dividends£12,513.39+£0
Total Interest£9.32    +£0
Total Profit from sales£18,047.83+£0
Average monthly cash profit£241.41(3.3%)-£0.45
(Sold stocks profit + Dividends
- Fees / Months)

Drop in value was mainly due to PBX:Probiotix Health and OPTI:Optibiotix, but potential profits went up £58 thanks to increases in AMRQ:Amaroq, BOKU:Boku and TRU:Trufin, all of which are recent purchases and 2 of which were using my new AIM magic formula. It's just a shame I'll never get to sell the older holdings so I can move them into my new strategy.


Still essentially flat


Still relentlessly following the trend line


Will it ever go up more than that blip?

The SIPP looks like this after week 522 overall and week 2 of year 11.




Weekly Change
Cash£1,117.03
+£25.85
Portfolio cost£143,096.38
+£879.00
Portfolio sell value
(bid price - commission)
£77,539.89(-45.8%)+£792.67
Potential profits£7,901.02
+£585.51
Yr 11 Dividends£35.20
+£25.85
Yr 11 Interest£0
+£0
Yr 11 Profit from sales£800.74
+£800.74
Yr 11 proj avg monthly profit£1,811.21(23.5%)+£1,770.71
Total Dividends£18,255.40
+£25.85
Total Interest£20.70
+£0
Total Profit from sales£25,467.25
+£800.74
Average monthly cash profit£349.67(4.5%)+£6.20

I sold 1,200 shares in PAF:Pan African Resources at 99.2114p making £800.75 (212%) profit. I wanted to keep the investment in gold, and after being spooked out of EDV:Endeavour Mining early in the year I decided to buy back in, purchasing 35 shares at 3505.156p costing £1,244.88. I'm hoping they will start paying dividends very shortly, and it spreads the risk a little in case anything happens to PAF.

I got a £25 dividend from UKW:Greencoat UK Wind and potential profits went up £585 despite realising £800 profit. Year 11 projected performance is silly because it's only week 2, whereas long term performance remained at 4.5% and only went up £6 a month. That is over 10 years though.


A teensy tick up


Fractionally above the trend line


More profit keeps me above the trend line.

OPTI:Optibiotix and JLP:Jubilee Metals have both given the news we were waiting for, and the share price has hardly budged, in fact it's dropped slightly for both. Any hopes for a quick resolution to my poor performance have been dashed, at least for now. Thankfully my new strategy is paying off, but it's such a small percentage of my portfolio that while the older shares are languishing, so is my overall performance. 

No comments:

Post a Comment